ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $28,168,000 | +45.6% | 696,863 | +107.3% | 0.01% | +16.7% |
| Q2 2015 | $19,346,000 | +103.8% | 336,158 | +125.4% | 0.01% | +100.0% |
| Q1 2015 | $9,494,000 | +143.9% | 149,115 | +136.5% | 0.00% | +200.0% |
| Q4 2014 | $3,893,000 | -74.9% | 63,043 | -84.2% | 0.00% | -83.3% |
| Q3 2014 | $15,480,000 | +164.2% | 398,693 | +134.4% | 0.01% | +500.0% |
| Q2 2014 | $5,859,000 | -51.6% | 170,100 | -39.3% | 0.00% | -75.0% |
| Q1 2014 | $12,105,000 | +102.5% | 280,174 | +86.7% | 0.00% | +100.0% |
| Q4 2013 | $5,979,000 | +23.1% | 150,068 | +16.1% | 0.00% | +100.0% |
| Q3 2013 | $4,856,000 | -1.4% | 129,306 | -29.5% | 0.00% | -50.0% |
| Q2 2013 | $4,927,000 | – | 183,381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |